Vistagen Therapeutics 10%+ Shareholder COMMODORE CAPITAL Reported Purchase of 775,756 @ Avg Price Of $23.15/Share in Form 4 Filing
Portfolio Pulse from Charles Gross
COMMODORE CAPITAL, a 10%+ shareholder in Vistagen Therapeutics, has reported a purchase of 775,756 shares at an average price of $23.15 per share, according to a Form 4 filing.
August 09, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
COMMODORE CAPITAL, a significant shareholder in Vistagen Therapeutics, has increased its stake by purchasing 775,756 shares at an average price of $23.15 per share.
Insider buying, especially by significant shareholders, is often seen as a positive sign by the market as it indicates confidence in the company's prospects. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100